4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059636
Director bought 362,500 shares at $15.00 ($5,437,500)
- Director acquired 7,549,570 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harrison Seth Loring Director | 2014-09-22 | Conversion | +7,549,570 | 7,549,579 | I: show line 1 in the form | ||
| Harrison Seth Loring Director | 2014-09-22 | Purchase | +362,500 | $15.00 | $5,437,500 | 7,912,079 | I: show line 2 in the form |
| Open-market purchases · 362,500 sh · avg $15.00 · $5,437,500 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series A Preferred Stock | −4,500,000 | 0 | I: show line 3 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series B-1 Preferred Stock | −798,067 | 0 | I: show line 4 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series B-2 Preferred Stock | −644,786 | 0 | I: show line 5 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series C Preferred Stock | −14,604,833 | 0 | I: show line 6 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series D-1 Preferred Stock | −8,711,335 | 0 | I: show line 7 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series D-2 Preferred Stock | −1,539,643 | 0 | I: show line 8 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series D-3 Preferred Stock | −24,046,035 | 0 | I: show line 9 in the form | |||||
| Harrison Seth Loring Director | 2014-09-22 | Conversion · Series E Preferred Stock | −24,199,308 | 0 | I: show line 10 in the form |
Loading xslF345X03/doc4.xml…